GAL, via GAL2R, promoted the proliferation of SCLC cells through an autocrine manner [88,113,150,151,173]; however, it is currently unknown whether or not GAL2R antagonists exert an antitumor action against SCLC cells. Here, GAL is linked to small cell lung carcinoma.